Caroline's Feed
Sep 16, 2013

Roche picks Lufthansa boss Franz as new chairman

ZURICH, Sept 16 (Reuters) – Roche has picked
Deutsche Lufthansa Chief Executive Christoph Franz to
succeed Franz Humer as chairman of its board, filling the top
post at a time of change for the world’s biggest maker of cancer
drugs.

Franz, 53, who has been a member of Roche’s board since
2011, will stand for election at Roche’s annual shareholder
meeting on March 4, the Swiss drugmaker said on Monday.

Sep 1, 2013

Alpine Wrestling festival spotlights brawn, Swiss pride

BURGDORF, Switzerland (Reuters) – Matthias Sempach, a 27-year-old farmer and butcher, knew exactly what he had to do to earn his title on Sunday of “King of the Alpine Wrestlers”: hang onto his opponent’s shorts.

Sempach was one of the “baddies”, as Switzerland’s best wrestlers are known, who pitted it out in a two-day contest that drew more than 250,000 people to the cheesemaking region of Emmental for the Swiss Wrestling and Alpine Herdsman Games.

Aug 30, 2013

Zurich Insurance says looking at whether undue pressure placed on CFO

ZURICH (Reuters) – Zurich Insurance Group will investigate whether excessive pressure was put on the company’s finance chief ahead of his apparent suicide, the company’s acting chairman said on Friday.

Europe’s third-largest insurer has been thrown into disarray by the death of Pierre Wauthier on Monday and the subsequent resignation of its chairman, former Deutsche Bank (DBKGn.DE: Quote, Profile, Research) boss Josef Ackermann, three days later.

Aug 30, 2013

Zurich Insurance looking if undue pressure put on suicide CFO

ZURICH (Reuters) – Zurich Insurance Group will investigate whether excessive pressure was put on the company’s finance chief ahead of his apparent suicide, the company’s acting chairman said on Friday.

Europe’s third-largest insurer has been thrown into disarray by the death of Pierre Wauthier on Monday and the subsequent resignation of its chairman, former Deutsche Bank (DBKGn.DE: Quote, Profile, Research, Stock Buzz) boss Josef Ackermann, three days later.

Aug 27, 2013

Roche looks to replicate cancer success with eye drugs

ZURICH, Aug 27 (Reuters) – Positive results for Roche’s
experimental eye drug should bolster its position in
the multibillion-dollar-a-year market for vision loss
treatments, as it looks to branch out beyond its core cancer
expertise.

After scrapping drugs to treat diabetes and boost levels of
“good” high-density cholesterol, the world’s largest maker of
cancer drugs is hoping to prove it has a stronger hand when it
comes to developing treatments for the eyes.

Aug 22, 2013

Nobel Biocare sales grow for first time in two years

ZURICH, Aug 22 (Reuters) – Swiss dental implant maker Nobel
Biocare Holding stuck to a forecast for higher market
share and revenue in 2013 after chalking up its first quarterly
sales growth at constant exchange rates in two years.

Dental implant makers have grappled with falling sales and
profit margins as cash-strapped consumers cut back on cosmetic
dentistry, which is generally not reimbursed by insurers.

Aug 20, 2013

Straumann signals appetite for low-cost dental players

ZURICH, Aug 20 (Reuters) – Straumann, the world’s
largest maker of dental implants, could spend over $400 million
on buying cheaper rivals, signalling a desire to grab back
market share from low-cost competitors.

Faced with sluggish demand in its main market of Europe,
analysts and investors have urged Straumann and fellow premium
rival Nobel Biocare to develop cheaper brands to
compete in the fast-growing area of the market, which now
accounts for roughly 60 percent of volumes.

Aug 14, 2013

Novartis chairman floats idea of business review to appease investors

ZURICH, Aug 14 (Reuters) – Less than two weeks into the job,
Novartis AG’s new chairman is seeking to appease
investors by suggesting the Swiss drugmaker will review some of
its underperforming businesses in coming weeks.

Global drugmakers have stepped up the pace of restructuring,
as investors clamour for management to unlock value trapped
inside large firms.

Aug 8, 2013

Adecco sees European labor markets at turning point

ZURICH (Reuters) – European labor markets have reached a turning point, world No. 1 staffing firm Adecco (ADEN.VX: Quote, Profile, Research, Stock Buzz) said on Thursday, as it beat second-quarter profit expectations and saw its shares surge to a two-and-a-half year high.

Staffing firms are regarded by analysts as good indicators of future economic trends and Adecco’s more optimistic tone about the euro zone could add to expectations it will move out of recession later this year.

Aug 7, 2013

Venture capital warms to European biotechs

ZURICH (Reuters) – While a wave of stock market enthusiasm in the United States for biotech company flotations has yet to cross the Atlantic, venture capital appetite for promising European companies is returning.

Biotech is hot on Wall Street, with the Nasdaq sector index up 43 percent this year, listed U.S. stocks scaling all-time highs and roughly 23 biotech companies going public.